Novo Nordisk (NVO) Q3 2026 Earnings
Aug 4Confirmed
Q4 2025
Q1 2026
Q2 2026
Q3 2026
0.71
0.81
0.92
1.02
Details
Expected EPS
0.766601718
Actual EPS
0.941832
Surprise EPS
0.18
Surprise Percent
+22.86%
Description
Prediction
91%
Community
Predictions and Polymarket odds are not investment advice, are not guaranteed, and may change. All investments involve risk, including loss of principal.
12 Comments
David
Just in my circle, 2 people are on the treatment, and now France is reimbursing it. The numbers can only get better.
BEAT
5
